Chung Man Ho Martin

Accredited in Dermatology & Venereology, Rheumatology and Internal Medicine | Associate Consultant at Queen Mary Hospital 🇭🇰 | @HKUmed

[JAMA Dermatology @JAMADerm]

Viewpoint: JAK inhibitors may boost the effectiveness of immune checkpoint inhibitors in some cancers, offering treatment options for patients with both autoimmune conditions and cancer. https://t.co/68w0wE5veO

[Chung Man Ho Martin @DrMartinChung]

@JasmineWongMed @AamirNHussain @KareenaGarg_Med Great work and congratulations!🎉

[Chung Man Ho Martin @DrMartinChung]

Hong Kong Society of Dermatology and Venereology
Annual Scientific Meeting 2024

We are incredibly honored to have had a distinguished panel of prestigious speakers from across the globe who graced us with their expertise in the field of dermatology!

[JAAD Journals @JAADjournals]

Given its ubiquitous presence, #petroleum jelly is a widely used topical agent and has wide-ranging uses and benefits in #dermatology. It is important for dermatologists to understand the history, safety profile, and myths surrounding this skincare staple. https://t.co/5F7Bm4jLdP

[NEJM @NEJM]

In the FRONTIER 1 trial involving 255 patients with moderate-to-severe plaque psoriasis, the oral interleukin-23–receptor antagonist peptide JNJ-77242113 showed a dose–response relationship and greater efficacy than placebo within 16 weeks. Full results: https://t.co/iIALfk6fas

[AnnalsSG @AnnalsSG]

Our sincere thanks to the following peer reviewers who completed and returned their reviews between 1 January 2023 and 31 December 2023. Your expertise and time generously given have been major factors in maintaining the Annals’ high standards. Full list:
https://t.co/trbCqPy6OD

[Chung Man Ho Martin @DrMartinChung]

With also a case of Toxic epidermal necrolysis in burn unit and
Paedi consult with phakomatosis pigmentovascularis type II !

[Chung Man Ho Martin @DrMartinChung]

Another day of combined rheum/derm clinic
- TIF1 +ve dermatomyositis with no malignancy
- SLE with cutaneous flare despite belimumab
- severe eczema for abrocitinib
- CSU failing cycA / omalizumab
- paraneoplastic pemphigus (underlying sarcoma)
- PsO with Ca larynx
Etc.

[Chung Man Ho Martin @DrMartinChung]

Last conference of the year !

Glad to share the role of dermatologists in the management of chronic leg ulcers at the Annual Scientific Meeting 2023 of the Hong Kong College of Dermatologists (HKCD)

#dermatology #legulcer
#livedoidvasculopathy #pyodermagangrenosum #Martorell

[Chung Man Ho Martin @DrMartinChung]

Honored to have participated in the expert roundtable meeting alongside local psoriasis experts. We all thoroughly enjoyed the inspiring talk from Prof. Strober and are excited about the availability of a new class of drug !

#psoriasis #TYK2 #derm #deucravacitinib

[NEJM @NEJM]

In this trial of 274 patients with prurigo nodularis, a debilitating neuroimmune skin disease, the interleukin-31 receptor antagonist nemolizumab significantly reduced severe itching and lesions. Read the full OLYMPIA 2 trial results: https://t.co/nWw6UEH22U

[Chung Man Ho Martin @DrMartinChung]

A typical day of inpatient dermatology
New consultations and admissions today
- fixed drug eruption
- bullous pemphigoid x 2
- SDRIFE
- pemphigus vulgaris for rituximab
- erythema multiforme
- erythrodermic eczema flare

Fruitful ! 🤓

[Chung Man Ho Martin @DrMartinChung]

Hong Kong Dermatology Symposium 2023
Grateful for the opportunity to present on immune checkpoint inhibitor induced cutaneous irAE

#checkpointinhibitor #cancer #medX #MedTwitter #dermatology

[Chung Man Ho Martin @DrMartinChung]

@glodermalliance It was a great lecture by the two giants in Dermatology ! Truly enjoyable

[Tsvetoslav Georgiev @GeorgievMD]

#Gout study reveals potential risks with prophylactic use of #colchicine or #NSAIDs when initiating allopurinol. Diarrhea, MI, and more found to be more common w/ colchicine while angina, AKI, PU w/ NSAIDs prophylaxis. Changing decision-making?#Allopurinol
https://t.co/E1coYReoC1

[Chung Man Ho Martin @DrMartinChung]

@loeymak 👍👍👍

[Chung Man Ho Martin @DrMartinChung]

HKU Dermatology team !
(The University of Hong Kong / Queen Mary Hospital)

#hkuderm #MedTwitter #medx #dermtwitter #dermatology

[Chung Man Ho Martin @DrMartinChung]

After work derm path !
Vasculopathy VS Vasculitis

#dermpath #derm #dermtwitter #medtwitter #MedX #vasculitis #livedoidvasculopathy

[Chung Man Ho Martin @DrMartinChung]

Speaking at the Annual Scientific Meeting 2023 ( Hong Kong Society of Dermatology and Venereology )

#ASM2023 #MedTwitter #MedX #Derm
#Dermtwitter #dermX #HKSDV #HKDerm #dermatology

[Chung Man Ho Martin @DrMartinChung]

Frequently asked question in clinic
-can I taper my dupi?
#MedTwitter #eczema #dupilumab #derm

Successful tapering of dupilumab in patients with atopic dermatitis with low disease activity: a large pragmatic daily practice study from the BioDay registry https://t.co/Colz0FqefM